pharma · Colitis, Ulcerative
Bausch + Lomb
Bausch + Lomb Ireland Limited
Bausch + Lomb is a pharma organization headquartered in GB. Primary therapeutic focus areas include Colitis, Ulcerative. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entit
Waterford, IE HQ
1853 Founded
167 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Waterford, IE
- Founded
- 1853
- Employees
- 167
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Budesonide
Phase 3 · small molecule · Colitis, Ulcerative
Budesonide for Colitis, Ulcerative is a Phase 3 program (small_molecule) at Bausch + Lomb Ireland Limited with 1 ClinicalTrials.gov record(s).
Internal code CB-01-02/06
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Bausch + Lomb Ireland Limited
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Colitis, Ulcerative
- Status
- completed
- Trials
- 1